Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Myeloma Knowledge Exchange 2019 (MyKE Myeloma) /
Artificial intelligence and treatment decisions

10th - 11th May 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 24.05.19
Views: 1363

Dr Pratik Shah - Massachusetts Institute of Technology, Cambridge, USA

Dr Pratik Shah speaks to ecancer at the 2019 MyKE Myeloma meeting in Barcelona about the use of artificial intelligence (AI) to guide treatment decisions.

Dr Shah gives examples of how AI can be used in the healthcare setting - which include the use of computational images for pathological staining and algorithms to determine dose recommendations to limit toxicity in glioblastoma patients.

He also describes some of the ethical concerns that should be considered while using this type of technology in this way and the benefits AI can provide to healthcare professionals and patients.

Within the next 5 years, Dr Shah hopes that this technology will become more accessible and safer for both patients and physicians to use; along with increasing its scalability.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation